[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1956 Introduced in House (IH)]







108th CONGRESS
  1st Session
                                H. R. 1956

 To amend part B of title XVIII of the Social Security Act to provide 
 coverage of certain self-administered intramuscular and subcutaneous 
                   drugs under the Medicare Program.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 6, 2003

Mr. Greenwood (for himself, Mr. Waxman, Mr. Van Hollen, Mr. Gutierrez, 
   Mr. Frank of Massachusetts, Mr. Holt, Mr. Frost, Mr. McNulty, Mr. 
    Doyle, Mr. Kildee, Mr. Kennedy of Rhode Island, Mr. Owens, Ms. 
 Schakowsky, Ms. Slaughter, Mr. Sanders, Mr. Pallone, Mr. Israel, Mr. 
     Collins, Mr. Ferguson, Mr. Rangel, Mr. Engel, Mr. Leach, Mr. 
    Nethercutt, Mr. Bishop of New York, and Mr. Moran of Virginia) 
 introduced the following bill; which was referred to the Committee on 
   Energy and Commerce, and in addition to the Committee on Ways and 
 Means, for a period to be subsequently determined by the Speaker, in 
   each case for consideration of such provisions as fall within the 
                jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend part B of title XVIII of the Social Security Act to provide 
 coverage of certain self-administered intramuscular and subcutaneous 
                   drugs under the Medicare Program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. COVERAGE OF CERTAIN SELF-ADMINISTERED INTRAMUSCULAR AND 
              SUBCUTANEOUS DRUGS UNDER THE MEDICARE PROGRAM.

    (a) In General.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)) is amended --
            (1) by striking ``and'' at the end of subparagraph (U);
            (2) by inserting ``and'' at the end of subparagraph (V); 
        and
            (3) by adding at the end of the following new subparagraph:
            ``(W) in the case of a disease where an intramuscular 
        biological therapy has approval of the Federal Food and Drug 
        Administration for patient self-administration upon physician 
        determination of appropriateness and is covered under 
        subparagraph (A) or (B) of this paragraph, any intramuscular 
        and subcutaneous drug and biological with a similar approved 
        use by such Administration (including the same biological 
        delivered by intramuscular injection which is covered by either 
        such subparagraph) without regard to whether there is medical 
        or other supervision with respect to the administration of such 
        drug or biological;''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply to drugs furnished on or after January 1, 2004.
                                 <all>